Imc Chicago, LLC Crispr Therapeutics Ag Transaction History

Imc Chicago, LLC

$2.69 Billion
Q1 2024

A detailed history of Imc Chicago, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Imc Chicago, LLC holds 36,722 shares of CRSP stock, worth $1.97 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

36,722

Previous 38,217 3.91%

Holding current value

$1.97 Million

Previous $2.39 Million 4.6%

% of portfolio

0.09%

Previous 0.08%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$60.67 - $89.12 $90,701 - $133,234	-1,495 Reduced 3.91%	36,722 $2.5 Million
Q4 2023 Feb 09, 2024	BUY	$38.62 - $72.18 $267,018 - $499,052	6,914 Added 22.09%	38,217 $2.39 Million
Q3 2023 Oct 12, 2023	BUY	$45.39 - $59.0 $709,899 - $922,760	15,640 Added 99.85%	31,303 $1.42 Million
Q2 2023 Jul 14, 2023	BUY	$43.47 - $67.77 $75,246 - $117,309	1,731 Added 12.42%	15,663 $879,000
Q1 2023 Apr 24, 2023	SELL	$41.0 - $56.12 $285,934 - $391,380	-6,974 Reduced 33.36%	13,932 $630,000

Q4 2022 Feb 09, 2023	BUY	$39.19 - $65.67 $819,306 - $1.37 Million	20,906 New	20,906 $850,000
Q2 2022 Aug 05, 2022	SELL	$43.23 - $73.83 $950,800 - $1.62 Million	-21,994 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$53.19 - $79.24 $1.28 Million - $1.91 Million	-24,086 Reduced 52.27%	21,994 $1.38 Million
Q4 2021 Feb 08, 2022	BUY	$70.09 - $111.29 $1.26 Million - $2.01 Million	18,036 Added 64.31%	46,080 $3.49 Million
Q3 2021 Nov 05, 2021	BUY	$110.2 - $156.64 $1.69 Million - $2.4 Million	15,291 Added 119.9%	28,044 $3.14 Million
Q2 2021 Aug 06, 2021	SELL	$100.84 - $161.89 $773,140 - $1.24 Million	-7,667 Reduced 37.55%	12,753 $2.07 Million
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $2.26 Million - $4.29 Million	20,420 New	20,420 $2.49 Million

Others Institutions Holding CRSP

# of Institutions

549

Shares Held

56.3M

Call Options Held

2.91M

Put Options Held

2.47M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.19B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Imc Chicago, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Imc Chicago, LLC with notifications on news.

Account